75 related articles for article (PubMed ID: 10633477)
21. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
[TBL] [Abstract][Full Text] [Related]
22. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
23. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study.
Ramirez J; Garnica R; Boll MC; Montes S; Rios C
Schizophr Res; 2004 Jun; 68(2-3):357-61. PubMed ID: 15099617
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder.
Clinton SM; Meador-Woodruff JH
Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.
Wang AK; Miller BJ
Schizophr Bull; 2018 Jan; 44(1):75-83. PubMed ID: 28338954
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals.
Gerner RH; Merrill JE
Biol Psychiatry; 1983 May; 18(5):565-9. PubMed ID: 6860728
[No Abstract] [Full Text] [Related]
27. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL
Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
29. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Zavitsanou K; Katsifis A; Mattner F; Huang XF
Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
[TBL] [Abstract][Full Text] [Related]
30. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
31. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia.
Linkowski P; Geenen V; Kerkhofs M; Mendlewicz J; Legros JJ
Eur Arch Psychiatry Neurol Sci; 1984; 234(3):162-5. PubMed ID: 6489403
[TBL] [Abstract][Full Text] [Related]
33. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.
Strasser HC; Lilyestrom J; Ashby ER; Honeycutt NA; Schretlen DJ; Pulver AE; Hopkins RO; Depaulo JR; Potash JB; Schweizer B; Yates KO; Kurian E; Barta PE; Pearlson GD
Biol Psychiatry; 2005 Mar; 57(6):633-9. PubMed ID: 15780850
[TBL] [Abstract][Full Text] [Related]
34. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism in SNAP29 gene promoter region associated with schizophrenia.
Saito T; Guan F; Papolos DF; Rajouria N; Fann CS; Lachman HM
Mol Psychiatry; 2001 Mar; 6(2):193-201. PubMed ID: 11317222
[TBL] [Abstract][Full Text] [Related]
36. Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder.
Davis KA; Kwon A; Cardenas VA; Deicken RF
J Affect Disord; 2004 Nov; 82(3):475-85. PubMed ID: 15555701
[TBL] [Abstract][Full Text] [Related]
37. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
[TBL] [Abstract][Full Text] [Related]
38. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.
Rimol LM; Hartberg CB; Nesvåg R; Fennema-Notestine C; Hagler DJ; Pung CJ; Jennings RG; Haukvik UK; Lange E; Nakstad PH; Melle I; Andreassen OA; Dale AM; Agartz I
Biol Psychiatry; 2010 Jul; 68(1):41-50. PubMed ID: 20609836
[TBL] [Abstract][Full Text] [Related]
39. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model.
Levine J; Sela BA; Osher Y; Belmaker RH
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1181-91. PubMed ID: 16115716
[TBL] [Abstract][Full Text] [Related]
40. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
Digney A; Keriakous D; Scarr E; Thomas E; Dean B
Biol Psychiatry; 2005 Apr; 57(7):711-5. PubMed ID: 15820227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
